top of page

A NEW DIMENSION IN POINT-OF-CARE BLOOD TESTING

PRODUCTS-THE EPINEX SIMPLYSURE PT-INR BLOOD COAGULATION TEST 

The Epinex SimplySure PT-INR Test

 

The SimplySure PT-INR (Prothrombin Time-International Normalized Ratio) Test for whole blood coagulation leverages a unique, patented technology that provides a visual quantitative reading directly on the test strip without the need of an expensive external test instrument.

 

Existing tests for PT-INR are based on electrochemical detection using chemical sensors and digital detection by means of an expensive external reader device. The SimplySure test is a microfluidic device that causes the blood sample move across a chemical laden strip by a certain distance that equates to what the PTINR test measures.

Features of the Epinex SimplySure PT-INR Test

  • The first quantitative, “un-plugged” whole blood coagulation test for PT/INR!

  • No capital expenditure, No instrument needed

  • Uses a few drops of whole blood

  • Point-of-Care convenience – Healthcare providers can test patients or have patients test themselves at home.

  • Fast Results – typically in less than three minutes.

  • Easy to use – runs like a glucose test and reads like a thermometer.

  • Compact & Disposable device

  • Patent protected (US patent 6,759,009, issued July 2004)

     

     

     

     

     

     

     

     

     

Epinex SimplySure PT-INR ADVANTAGE OVER THE COMPETTION

  • SimplySure PT-INR does not require complex and costly instrumentation for testing.

  • All competition requires upfront instrument/device cost >$900.

  • Simplicity and cost effectiveness of SimplySure PT-INR enables easy physician office or self-testing without need for additional infrastructure or patient assistance.

  • Disposable test design facilitates INR monitoring at any time any place.

     

     

     

     

     

     

     

     

     

* This product is under development and is intended for information and evaluation purposes only. It is NOT APPROVED by the USFDA.

bottom of page